Pediatric cardiomyopathy as a chronic disease: A perspective on comprehensive care programs

Progress in Pediatric Cardiology

Volumn 25, Issue 1, 2008, Pages 103-111

  Bublik, Natalya ^a   Alvarez, Jorge A ^a   Lipshultz, Steven E ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Comprehensive programs; Multidisciplinary programs; Pediatric cardiomyopathy; Pediatric heart failure

Indexed keywords

ARTICLE; CARDIOMYOPATHY; CHILD; CHRONIC DISEASE; CONSENSUS; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; HEALTH CARE; HEALTH CARE MANAGEMENT; HEALTH PROGRAM; HEART FAILURE; HOSPITAL ADMISSION; HOSPITAL CHARGE; HUMAN; LENGTH OF STAY; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

EID: 40949084269     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ppedcard.2007.11.011     Document Type: Article

References (51)

1. Lipshultz S.E., Sleeper L.A., Towbin J.A., et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348 17 (Apr 24 2003) 1647-1655
2. Towbin J.A., Lowe A.M., Colan S.D., et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 296 15 (Oct 18 2006) 1867-1876
3. Colan S.D., Lipshultz S.E., Lowe A.M., et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation 115 6 (Feb 13 2007) 773-781
4. Boucek M.M., Faro A., Novick R.J., Bennett L.E., Keck B.M., and Hosenpud J.D. The Registry of the International Society for Heart and Lung Transplantation: Fourth Official Pediatric Report-2000. J Heart Lung Transplant 20 1 (Jan 2001) 39-52
5. Moller J.H., Allen H.D., Clark E.B., et al. Report of the task force on children and youth. American Heart Association. Circulation 88 5 Pt 1 (Nov 1993) 2479-2486
6. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 5 (Feb 6 2007) e69-e171
7. Healthcare Cost and Utilization Project. http://www.hcup-us.ahrq.gov/overview.jsp. Accessed October 25 2007.
8. Dayton J.D., Kanter K.R., Vincent R.N., and Mahle W.T. Cost-effectiveness of pediatric heart transplantation. J Heart Lung Transplant 25 4 (Apr 2006) 409-415
9. Silber J.H., Gleeson S.P., and Zhao H. The influence of chronic disease on resource utilization in common acute pediatric conditions. Financial concerns for children's hospitals. Arch Pediatr Adolesc Med 153 2 (Feb 1999) 169-179
10. Liptak G.S., Burns C.M., Davidson P.W., and McAnarney E.R. Effects of providing comprehensive ambulatory services to children with chronic conditions. Arch Pediatr Adolesc Med 152 10 (Oct 1998) 1003-1008
11. Beck J.K., Logan K.J., Hamm R.M., et al. Reimbursement for pediatric diabetes intensive case management: a model for chronic diseases?. Pediatrics 113 1 Pt 1 (Jan 2004) e47-e50
12. Rich M.W., Beckham V., Wittenberg C., Leven C.L., Freedland K.E., and Carney R.M. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333 18 (Nov 2 1995) 1190-1195
13. Fonarow G.C., Stevenson L.W., Walden J.A., et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol 30 3 (Sep 1997) 725-732
14. Fonarow G.C., Abraham W.T., Albert N.M., et al. Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF). Arch Intern Med 167 14 (Jul 23 2007) 1493-1502
15. Anderson C., Deepak B.V., Amoateng-Adjepong Y., and Zarich S. Benefits of comprehensive inpatient education and discharge planning combined with outpatient support in elderly patients with congestive heart failure. Congest Heart Fail (Greenwich Conn) 11 6 (Nov-Dec 2005) 315-321
16. Berkowitz R., Blank L.J., and Powell S.K. Strategies to reduce hospitalization in the management of heart failure. Lippincotts Case Manag 10 6 Suppl (Nov-Dec 2005) S1-S15 [quiz S16-17]
17. Gwadry-Sridhar F.H., Flintoft V., Lee D.S., Lee H., and Guyatt G.H. A systematic review and meta-analysis of studies comparing readmission rates and mortality rates in patients with heart failure. Arch Intern Med 164 21 (Nov 22 2004) 2315-2320
18. Phend C. ACC: Mixed messages on heart failure disease management.www.medpagetoday.com/Cardiology/2005ACCMeeting/tb/5370. Accessed on November 7, 2007.
19. American Heart Association. Get with the guidelines. http://www.americanheart.org/presenter.jhtml?identifier=1165. Accessed November 7, 2007.
20. Children's Cardiomyopathy Foundation. Vision Statement. http://www.childrenscardiomyopathy.org/site/vision.php. Accessed October 19, 2007.
21. Cystic Fibrosis Foundation. http://www.cff.org/treatments/CareCenterNetwork. Accessed October 19, 2007.
22. Cox G.F., Sleeper L.A., Lowe A.M., et al. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics 118 4 (Oct 2006) 1519-1531
23. K Uzark, MB Benedict, E Daberkow Carson, et al. Guidelines for Parent Support Groups. American Heart Association [http://www.americanheart.org/presenter.jhtml?identifier=1746. Accessed October 22, 2007.
24. Centers for Disease Control and Prevention. Chronic Disease Overview. http://www.cdc.gov/nccdphp/overview.htm. Accessed August 28, 2007.
25. Institute of Medicine. Crossing the quality chasm: a new health system for the twenty-first century (2001), National Academy Press, Washington
26. Wagner E.H., Austin B.T., Davis C., Hindmarsh M., Schaefer J., and Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff 20 6 (Nov-Dec 2001) 64-78
27. Alvarez J., Scully R., Miller T., et al. Long-term effects of treatments for childhood cancers. Curr Opin Pediatr 19 1 (2007) 23-31
28. Lipshultz SE, Alvarez JA, Scully RE. Anthracycline-associated cardiotoxicity in survivors of childhood cancer. Heart. In Press.
29. Oeffinger K.C., Mertens A.C., Sklar C.A., et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355 15 (Oct 12 2006) 1572-1582
30. Skinner R., Wallace W.H., and Levitt G.A. Long-term follow-up of people who have survived cancer during childhood. Lancet Oncol 7 6 (Jun 2006) 489-498
31. Bryant J., Picot J., Baxter L., Levitt G., Sullivan I., and Clegg A. Clinical and cost-effectiveness of cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review. Br J Cancer 96 2 (Jan 29 2007) 226-230
32. Lipshultz S.E., Giantris A.L., Lipsitz S.R., et al. Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 acute lymphoblastic leukemia protocol. J Clin Oncol 20 6 (Mar 15 2002) 1677-1682
33. Barry E., Alvarez J.A., Scully R.E., Miller T.L., and Lipshultz S.E. Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opin Pharmacother 8 8 (Jun 2007) 1039-1058
34. Lipshultz S.E., Lipsitz S.R., Sallan S.E., et al. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia. J Clin Oncol 23 (12 (Apr 20 2005) 2629-2636
35. Children's Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. http://www.survivorshipguidelines.org. Accessed November 2, 2007.
36. Oeffinger K.C., and McCabe M.S. Models for delivering survivorship care. J Clin Oncol 24 32 (Nov 10 2006) 5117-5124
37. Oeffinger K.C., and Wallace W.H. Barriers to follow-up care of survivors in the United States and the United Kingdom. Pediatr Blood Cancer 46 2 (Feb 2006) 135-142
38. Evans R.W. Economic and social costs of heart transplantation. Heart Transplant 1 3 (May 1982) 243-251
39. Evans R.W. The economics of heart transplantation. Circulation 75 1 (Jan 1987) 63-76
40. Evans R.W. Socioeconomic aspects of heart transplantation. Curr Opin Cardiol 10 2 (Mar 1995) 169-179
41. Sleeper L.A., Towbin J.A., Colan S.D., et al. Impaired functional status in children with cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry. Circulation S110 (2004) III-385
42. Parent to Parent-USA. http://www.p2pusa.org/. Accessed October 20, 2007.
43. Family Voices. Family Voices. http://www.familyvoices.org/. Accessed October 20, 2007.
44. Miller T.L., Neri D., Extein J., Somarriba G., and Strickman-Stein N. Nutrition in pediatric cardiomyopathy. Prog Pediatr Cardiol 24 1 (2007) 59-71
45. Somarriba G., Extein J., and Miller T.L. Exercise rehabilitation in pediatric cardiomyopathy. Prog Pediatr Cardiol (2007) 10.1016/j.ppedcard.2007.11.008
46. Gidding S.S. The importance of randomized controlled trials in pediatric cardiology. JAMA 298 10 (Sep 12 2007) 1214-1216
47. Shaddy R.E., Boucek M.M., Hsu D.T., et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 298 10 (Sep 12 2007) 1171-1179
48. Schwartz M.L., Cox G.F., Lin A.E., et al. Clinical approach to genetic cardiomyopathy in children. Circulation 94 8 (October 15, 1996) 2021-2038
49. Rosenthal D., Chrisant M.R., Edens E., et al. International Society for Heart and Lung Transplantation: practice guidelines for management of heart failure in children. J Heart Lung Transplant 23 12 (Dec 2004) 1313-1333
50. Lipshultz S.E. Realizing optimal care for children with cardiovascular disease: funding challenges and research approaches. Prog Pediatr Cardiol 20 1 (2005) 71-90
51. Lipshultz S.E. Ventricular dysfunction clinical research in infants, children and adolescents. Prog Pediatr Cardiol 12 1 (Nov 4 2000) 1-28